Major progress could be made in fighting the youth vaping epidemic with a complete restriction on sweet flavorings and cooling agents in both cartridge and disposable e-cigarette devices, according to a new study from the Center for Tobacco Research at The Ohio State University Comprehensive Cancer Center.
Silence unveils more PhI data for siRNA drug in new cardiovascular race targeting Lp(a)
Silence Therapeutics’ siRNA asset showed hints of efficacy in cardiovascular disease patients enrolled in a Phase I trial amid recent readouts from pipeline rivals backed